S&P 500   3,788.66 (+0.14%)
DOW   30,270.33 (-0.01%)
QQQ   282.26 (+0.10%)
AAPL   146.96 (+0.38%)
MSFT   250.12 (+0.37%)
META   139.07 (+0.06%)
GOOGL   102.58 (+1.13%)
AMZN   121.21 (+0.21%)
TSLA   242.41 (+0.66%)
NVDA   135.43 (+2.53%)
NIO   16.01 (-0.19%)
BABA   84.92 (+0.63%)
AMD   69.83 (+2.78%)
T   15.77 (-1.00%)
MU   55.05 (+0.58%)
CGC   3.13 (+1.95%)
F   12.50 (-0.08%)
GE   67.27 (-0.25%)
DIS   100.96 (+0.16%)
AMC   7.49 (+2.18%)
PYPL   94.55 (+0.77%)
PFE   43.67 (-1.02%)
NFLX   238.67 (+0.82%)
S&P 500   3,788.66 (+0.14%)
DOW   30,270.33 (-0.01%)
QQQ   282.26 (+0.10%)
AAPL   146.96 (+0.38%)
MSFT   250.12 (+0.37%)
META   139.07 (+0.06%)
GOOGL   102.58 (+1.13%)
AMZN   121.21 (+0.21%)
TSLA   242.41 (+0.66%)
NVDA   135.43 (+2.53%)
NIO   16.01 (-0.19%)
BABA   84.92 (+0.63%)
AMD   69.83 (+2.78%)
T   15.77 (-1.00%)
MU   55.05 (+0.58%)
CGC   3.13 (+1.95%)
F   12.50 (-0.08%)
GE   67.27 (-0.25%)
DIS   100.96 (+0.16%)
AMC   7.49 (+2.18%)
PYPL   94.55 (+0.77%)
PFE   43.67 (-1.02%)
NFLX   238.67 (+0.82%)
S&P 500   3,788.66 (+0.14%)
DOW   30,270.33 (-0.01%)
QQQ   282.26 (+0.10%)
AAPL   146.96 (+0.38%)
MSFT   250.12 (+0.37%)
META   139.07 (+0.06%)
GOOGL   102.58 (+1.13%)
AMZN   121.21 (+0.21%)
TSLA   242.41 (+0.66%)
NVDA   135.43 (+2.53%)
NIO   16.01 (-0.19%)
BABA   84.92 (+0.63%)
AMD   69.83 (+2.78%)
T   15.77 (-1.00%)
MU   55.05 (+0.58%)
CGC   3.13 (+1.95%)
F   12.50 (-0.08%)
GE   67.27 (-0.25%)
DIS   100.96 (+0.16%)
AMC   7.49 (+2.18%)
PYPL   94.55 (+0.77%)
PFE   43.67 (-1.02%)
NFLX   238.67 (+0.82%)
S&P 500   3,788.66 (+0.14%)
DOW   30,270.33 (-0.01%)
QQQ   282.26 (+0.10%)
AAPL   146.96 (+0.38%)
MSFT   250.12 (+0.37%)
META   139.07 (+0.06%)
GOOGL   102.58 (+1.13%)
AMZN   121.21 (+0.21%)
TSLA   242.41 (+0.66%)
NVDA   135.43 (+2.53%)
NIO   16.01 (-0.19%)
BABA   84.92 (+0.63%)
AMD   69.83 (+2.78%)
T   15.77 (-1.00%)
MU   55.05 (+0.58%)
CGC   3.13 (+1.95%)
F   12.50 (-0.08%)
GE   67.27 (-0.25%)
DIS   100.96 (+0.16%)
AMC   7.49 (+2.18%)
PYPL   94.55 (+0.77%)
PFE   43.67 (-1.02%)
NFLX   238.67 (+0.82%)
CVE:KDA

KDA Group - KDA Stock Forecast, Price & News

C$0.09
-0.02 (-18.18%)
(As of 10/4/2022 05:20 PM ET)
Add
Compare
Today's Range
C$0.09
C$0.09
50-Day Range
C$0.09
C$0.12
52-Week Range
C$0.07
C$0.17
Volume
1,000 shs
Average Volume
75,535 shs
Market Capitalization
C$13.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
KDA stock logo

About KDA Group (CVE:KDA) Stock

KDA Group Inc., together with its subsidiaries, offers solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates in three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, online and in-class training for pharmacists and pharmacy technical assistants, human resource and crisis management consulting services, private health services, pharmacy re-engineering services, and pharmaceutical training services. The company also offers software applications, such as Virtual Clinics, Virtual Pharmacy, and eCommerce for orders of medical cannabis products, as well as counselling and training services on medical cannabis products for doctors, pharmacists, and patients; and replacement and training services to dental personnel. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. was founded in 2008 and is headquartered in Thetford Mines, Canada.

Receive KDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KDA Group and its competitors with MarketBeat's FREE daily newsletter.

KDA Stock News Headlines

The 6 Best Team Assessment Tools
KDA officials told to sell vacant plots
The politics of demolitions
See More Headlines
Receive KDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KDA Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Distribution
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$26.40 million
Cash Flow
C$0.02 per share
Book Value
C$0.00 per share

Miscellaneous

Free Float
N/A
Market Cap
C$13.33 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Marc Lemieux
    Co-Founder, Chairman, CEO & Pres
  • Ms. Isabelle Begin
    Co-Founder, Exec. VP of Pharmacy Services Division & Director
  • Mr. Michael Winslow Kinley C.A. (Age 71)
    C.P.A., Interim CFO & Director
    Comp: $12k
  • Mr. Jean-Pierre Robert B.Sc.
    Chief Operating Officer
  • Mr. Pierre Monet
    Sec.
  • Dr. Giuseppe D'Aprano
    Chief Scientific Officer
  • Ms. Annie Mercier
    Controller
  • Mr. Jean-Marc Leveille
    Member of Strategic Advisory Board and Consultant of HR & Strategic Planning













KDA Stock - Frequently Asked Questions

How have KDA shares performed in 2022?

KDA Group's stock was trading at C$0.11 at the beginning of the year. Since then, KDA shares have decreased by 14.3% and is now trading at C$0.09.
View the best growth stocks for 2022 here
.

What is KDA Group's stock symbol?

KDA Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KDA."

How do I buy shares of KDA Group?

Shares of KDA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is KDA Group's stock price today?

One share of KDA stock can currently be purchased for approximately C$0.09.

How much money does KDA Group make?

KDA Group (CVE:KDA) has a market capitalization of C$13.33 million and generates C$26.40 million in revenue each year.

How can I contact KDA Group?

The official website for the company is www.alliancepharma.ca. The company can be reached via phone at 418-755-0821.

This page (CVE:KDA) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.